Royalty Report: Medical, Diagnostic, Ophthalmological – Collection: 26252


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Medical
  • Diagnostic
  • Ophthalmological

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 26252

License Grant
The University granted an exclusive license to make, use, sell, offer for sale, and import Licensee technology in development.
License Property
The intellectual property granted by the University is not specified in the source document. It has commercialized a proprietary tear testing platform that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Their first product measures tear film osmolarity for the diagnosis of Dry Eye Disease, or DED.
Field of Use
Through the Licencee's wholly-owned subsidiary it develops technologies to enable eye care practitioners to test a wide range of biomarkers (chemistries, metabolites (i.e. glucose), genes and proteins) at the point-of-care.  The Licensee is an in-vitro diagnostic company.

IPSCIO Record ID: 232881

License Grant
The parties restate the exclusive license agreement royalty terms for the commercial development of the invention disclosed in UCSD Disclosure Docket No. SD2002-180 and titled “Volume Independent Tear Film Osmometer” (UCSD License Agreement #2003-03-0433).
License Property
The present invention relates generally to measuring the osmotic pressure of fluids and, more particularly, to measuring the osmolarity of tear film.
Field of Use
The Licensee have commercialized a proprietary tear testing platform, the TearLab® Osmolarity System that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care.

IPSCIO Record ID: 3949

License Grant
We invested money into a newly formed 50/50 joint venture with another party, to bring to fruition R&D for innovative Point-of-care diagnostic tests.
License Property
The joint venture products will be focused on proprietary lateral flow and optics technologies (whereby a sample of saliva, urine, or whole blood moves across a solid platform to interact with a reagent to produce colorimetric or other changes that can be measured qualitatively or quantitatively) and Point-of-Care delivery of data through novel and inexpensive readers.
Field of Use
We intend to use lateral flow and optics intellectual property for the joint development of point of care diagnostic products for human, forensic and veterinary use.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.